SBI Mutual Fund, which previously held a 1.27 percent stake in Indegene Limited, is no longer listed among the company's major shareholders, signaling either a complete exit or a reduction to below the 1 percent reporting threshold.
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.
